Loading...
Mesalamine
India Pharmaceutical Trade Intelligence
Who Supplies Mesalamine to India from CHINA
India's mesalamine imports from CHINA total $1.8K across 26 shipments from 7 foreign suppliers. ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. leads with $617 in import value; the top 5 suppliers together control 96.5% of this origin. Leading Indian buyers include CLIANTHA RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for mesalamine — a diversified sourcing base with multiple active suppliers from CHINA.
Top foreign suppliers (CHINA) — Ranked by import value
ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. is the leading Mesalamine supplier from CHINA to India, with import value of $617 across 6 shipments. The top 5 suppliers — ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD., NOVAST LABORATORIES LIMITED, NOVAST LABORATORIES LTD., HAIMEN PHARMA INC.,, NOVAST LABORATORIES LTD.. — collectively account for 96.5% of total import value from this origin.
Top foreign suppliers (CHINA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. | $617 | 6 | 34.0% |
| 2 | NOVAST LABORATORIES LIMITED | $589 | 8 | 32.4% |
| 3 | NOVAST LABORATORIES LTD. | $351 | 8 | 19.3% |
| 4 | HAIMEN PHARMA INC., | $153 | 1 | 8.4% |
| 5 | NOVAST LABORATORIES LTD.. | $43 | 1 | 2.4% |
| 6 | NOVAST LABORATORIES LTD | $43 | 1 | 2.4% |
| 7 | ZHEJIANG HUAHAI PHARAMACEUTICAL CO. LIMITED | $20 | 1 | 1.1% |
Showing top 7 of 7 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CHINA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CLIANTHA RESEARCH LIMITED | $771 | 7 | 42.4% |
| 2 | RICONPHARMA INDIA PRIVATE LIMITED | $648 | 13 | 35.7% |
| 3 | ZENRISE CLINICAL RESEARCH PRIVATE LIMITED | $378 | 5 | 20.8% |
| 4 | ACTIMUS BIOSCIENCES PRIVATE LIMITED | $20 | 1 | 1.1% |
Import Statistics
- Import Value
- $1.8K
- Shipments
- 26
- Foreign Suppliers
- 7
- Indian Buyers
- 4
- Avg. Shipment
- $70
Other Mesalamine Import Origins
Related Analysis
Frequently Asked Questions — Mesalamine Imports from CHINA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Mesalamine suppliers from CHINA to India?
The top Mesalamine suppliers from CHINA to India include ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD., NOVAST LABORATORIES LIMITED, NOVAST LABORATORIES LTD.. The leading supplier is ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. with import value of $617 USD across 6 shipments. India imported Mesalamine worth $1.8K USD from CHINA in total across 26 shipments.
QHow much Mesalamine does India import from CHINA?
India imported Mesalamine worth $1.8K USD from CHINA across 26 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Mesalamine from CHINA?
The main Indian buyers of Mesalamine sourced from CHINA include CLIANTHA RESEARCH LIMITED, RICONPHARMA INDIA PRIVATE LIMITED, ZENRISE CLINICAL RESEARCH PRIVATE LIMITED. The largest buyer is CLIANTHA RESEARCH LIMITED with $771 in imports across 7 shipments.
QWhat is the total value of Mesalamine imports from CHINA to India?
The total value of Mesalamine imports from CHINA to India is $1.8K USD, across 26 shipments and 7 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CHINA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Mesalamine.
- 2.Supplier/Buyer Matching: 7 foreign suppliers from CHINA and 4 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $1.8K aggregated from 26 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
26 Verified Shipments
7 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists